Continuous stochastic damage contributes to the gradual attenuation of physiologic functions, which are partially alleviated by genetically encoded repair systems ([@b28]). Genetic determinants, which have a direct impact on these biological processes can be characterized by either studying model organisms that are amenable to genetic manipulations ([@b33]), or by applying functional genomic methods. Both strategies have helped to identify genes and proteins, which potentially modulate the aging process. Proteins identified in various studies have been compiled in a database only recently ([@b41]). Yet hardly any study has so far addressed the role of miRNAs during aging ([@b2]; [@b19]).

MiRNAs are a class of small non-coding silencing RNAs of approximately 22 nucleotides in length ([@b17]). They confer specificity to the RNA-induced silencing complex that either degrades or translationally represses target mRNAs ([@b3]; [@b9]). As the recognition of target mRNAs mainly depends on the small seed region within the mature miRNA, a single miRNA potentially regulates up to several hundred mRNA targets, thus orchestrating a large variety of cellular processes ([@b36]; [@b46]).

Here, we have set out to systematically compare miRNA transcription profiles in old vs. young human cells. Employed were *in vitro* replicative senescence of endothelial cells ([@b11]; [@b20]), renal proximal tubular epithelial cells ([@b50]), skin fibroblasts ([@b23]; [@b47]) as well as an intra-individual comparison of *in vivo* replicatively exhausted CD8^+^ T cells ([@b44]; [@b15]). Furthermore, we used bone-derived mesenchymal stem cells ([@b16]; [@b31]), foreskin ([@b42]), as well as CD8^+^ CD28^+^ T cells from old versus young donors ([@b32]). Detailed characterization of these models as well as an overview over biological and technical replicates and experimental design is presented in the supplements ([Figs S1](#SD1){ref-type="supplementary-material"} and [S2a](#SD2){ref-type="supplementary-material"}). Experiments were approved by the local ethical committees, and written informed consent is available from all donors.

Locked nucleic acid (LNA)-miRNA microarrays were spotted ([@b10]) using Sanger miRBase v9.2 ([@b18]) probe sets consisting of 559 human, 170 mouse, and 77 not yet annotated (miRPlus sequences; Exiqon Inc., Vedbaek, Denmark) miRNA probes. Microarray design, a comprehensive set of related protocols as well as raw and normalized intensity data have been submitted to Array Express Database compliant to Minimum Information About a Microarray Experiment standards ([@b6]; [@b5]). For Array Express accession numbers and detailed materials and methods see [Data S1](#SD7){ref-type="supplementary-material"} and [Fig. S2a](#SD2){ref-type="supplementary-material"}.

Depending on the experimental system, statistical analysis identified 10--20% of the miRNAs as regulated, while the majority remained unchanged during aging ([Table S1](#SD4){ref-type="supplementary-material"}). Applying hierarchical clustering of all regulated miRNAs, members of the miR-17-92 cluster and paralogous clusters stood out as being commonly down-regulated ([Fig. S3](#SD3){ref-type="supplementary-material"}).

Using linear models and moderated T-statistics ([@b45]) in combination with false discovery rate (FDR) adjustment according to [@b22], we calculated differential expression of miRNAs (FDR-adjusted *P*-value \< 0.05) for each of the seven model systems independently (available as tab-delimited sheet in [Table S2](#SD5){ref-type="supplementary-material"}). Intersections of these lists of regulated miRNAs were then analyzed for the replicative aging models and the *ex vivo* models, which resulted in five miRNAs with common expression changes in replicative aging, and 34 miRNAs that changed expression during organismal aging ([Fig. 1a](#fig01){ref-type="fig"}). Interestingly, both replicative and organismal aging share a common set of four miRNAs ('public miRNAs') that belong to the miR-17-92 cluster or its paralogous cluster miR-106a-363 and are down-regulated in both conditions ([Fig. 1b](#fig01){ref-type="fig"}). [Figure 1b](#fig01){ref-type="fig"} shows that microarray analysis identified miR-17 as significantly down-regulated in all seven model systems, while miR-19b and miR-20a are down-regulated in six and miR-106a in five of the seven model systems. Interestingly, three of these four miRNAs also share the same seed sequence ([Fig. 1c](#fig01){ref-type="fig"}) indicating a cooperative relief of translational inhibition of a common and important set of target genes. Although low transcription levels of mature miR-17 have been found in S phase cells compared to G0/G1 and G2/M phase HeLa cells ([@b12]), our result is not a mere growth arrest phenomenon, as miR-17 and miR-19b are not regulated in young replicating vs. quiescent endothelial cells (data not shown).

![Microarray analysis of differential expression and enrichment of regulated miRNAs in replicative and organismal aging. (a) Size-adjusted Venn diagram depicting the intersection of regulated miRNAs from replicative and organismal aging models: the upper, yellow circle represents five miRNAs that were found significantly regulated (false discovery rate-adjusted *P*-value \< 0.05) in at least three of the four replicative models. Only miRNAs with uniform up- or down-regulation in all models were considered. For organismal aging experiments, 34 miRNAs were significantly regulated (FDR-adjusted *P*-value \< 0.05) in at least two of three models, indicated by the lower, purple circle. (b) The intersection contains three miRNAs of the miR-17-92 cluster, namely miR-17, miR-19b, and miR-20a, as well as miR-106a of the paralogous miR-106a-363 cluster. The individual 'old vs. young' ratios for these miRNAs, calculated from microarray data, are depicted in a barchart. (c) Fold changes in transcription of young vs. old based on microarrays are given for all members of the miR-17-92 cluster as well as selected miRNAs from paralogous clusters together with 5′ seed sequences. Adjusted *P*-values \< 0.05 are marked in bold and underlined format, indicating statistically significant regulation.](ace0009-0291-f1){#fig01}

Using quantitative polymerase chain reaction, we confirmed the down-regulation of miR-17, miR-19b, miR-20a, and miR-106a ([Fig. 2a](#fig02){ref-type="fig"}) but observed a greater dynamic range in fold changes ranging up to a 6-fold down-regulation, thus indicating an even stronger decrease in the transcription of all four miRNAs with age.

![Quantitative real-time polymerase chain reaction (PCR) of miRNAs and the published target p21/CDKN1A. (a) Down-regulation of miR-17, miR-19b, miR-20a, and miR-106a in microarray experiments was validated by quantitative PCR analysis. miRNA expression values were normalized to GAPDH levels for each experiment (*n* = 8; *P* \< 0.05, one sample *t*-test with μ~0~ = 0) (b) Messenger RNA levels of p21/CDKN1A were analyzed by quantitative polymerase chain reaction and normalized to GAPDH expression levels (*n* = 8; *P* \< 0.05, one sample *t*-test with μ~0~ = 0). Increased p21 levels were observed in senescence and organismal aging indicating negative correlation to transcription of members of the miR-17-92 cluster. HDF: human diploid fibroblasts, HUVEC: human umbilical vein endothelial cells, RPTEC: renal proximal tubular epithelial cells, MSC: bone marrow derived mesenchymal stem cells, FSK: human foreskin, GAPDH: Glycerinaldehyd-3-phosphat-Dehydrogenase.](ace0009-0291-f2){#fig02}

Down-regulation of members of the miR-17-92 cluster has been reported recently in age-related conditions like in stress-induced senescence ([@b34]), after p53 induction ([@b7]) as well as after low level irradiation ([@b38],[@b39];) of human fibroblasts.

However, other reports on differential expression of miRNAs in replicative senescence of fibroblasts ([@b7]; [@b30]; [@b4]; [@b40]), in senescence of mesenchymal stem cells ([@b49]), of human and mouse brain tissue ([@b37]; [@b35]) as well as of murine liver ([@b38],[@b39];) and lung ([@b52]; [@b26]) do not explicitly report regulation of miR-17-92 miRNAs. This might either be because of the fact that in some studies only up-regulated miRNAs have been reported or to the strategy that only at least 2-fold changed miRNAs were considered.

As the ability of array platforms to detect fold changes down to 1.3-fold ([@b54]) and because LNA-based microarray methodology is considered to be one of the most sensitive and reliable at the moment ([@b51]), we included miR-17-92 cluster members that are significantly regulated even at levels below 2-fold, even more so, because array results also are reported to have the tendency to underestimate the ratios ([@b54]).

Interestingly, among the published targets of the miR-17-92, cluster is p21/CDKN1A mRNA ([@b25]; [@b24]). Indeed, p21/CDKN1A mRNA levels are negatively correlated in all model systems ([Fig. 2b](#fig02){ref-type="fig"}), although the ratio in old vs. young T cells does not reach significance.

These data indicate that the miR-17-92 cluster, which is known to contribute to transcriptional regulation in cell cycle control and tumorigenesis ([@b21]), also contributes to transcriptional regulation in senescence and aging, consistent with the known interdependence between senescence and tumorigenesis ([@b8]; [@b43]).

Among others, E2F transcriptionally activates ([@b53]) and p53 represses the miR-17-92 cluster ([@b55]). Thus, decreased miR-17-92 levels are consistent with the notion that, E2F family members decrease ([@b13]), while p53 activity increases in senescence ([@b1]; [@b29]).

Downstream of miR-17-92 are 19 experimentally confirmed mRNA targets besides p21. Many of them are involved in tumorigenesis and cell cycle control ([Table S3](#SD6){ref-type="supplementary-material"}). Indeed, miR-17-92 suppression induces growth arrest in anaplastic thyroid cancer cell models ([@b48]). Furthermore, an increase in the level of miR-17-92 is associated with a decrease in ROS and DNA damage in RB mutated tumor cells ([@b14]). It will be exciting to test in an experimental system whether a decrease in miR-17-92, as detected in our models of aging, conversely results in more ROS and DNA damage, both well accepted driving forces of age-related functional decline.

In summary, our results implicate specific changes of miRNA abundance and activity in a broad range of human aging models and suggest the use of miR-17, miR-19b, miR-20a, and miR-106 as novel biomarkers of cellular aging.
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